|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 149.00 GBX | +3.11% |
|
+12.88% | +16.41% |
| 07-29 | Diaceutics PLC Reports Revenue Results for the Half Year Ended 30 June 2026 | CI |
| 06-02 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | - | 2.98x | 2.45x | 11.18x | 35.8x | 165M | ||
| -.--% | -.--% | -105.65x | 9.6x | 21.63x | 54.65x | -87.41x | 57.8B | ||
| 1.5% | 2.08% | 31.74x | 3.36x | 2.36x | 20.36x | 34.53x | 3.46B | ||
| 0.26% | 0.34% | 97.99x | 6.36x | 12.53x | 19.53x | 115.97x | 3.35B | ||
| 1.96% | 2.17% | 36.07x | 13.4x | 11.74x | 25.09x | 28.98x | 2.1B | ||
| 0.09% | - | -86.67x | 4.33x | - | - | - | 1.48B | ||
| 0.66% | 0.8% | 27.05x | 2.19x | 3.6x | 14.57x | 18.95x | 1.25B | ||
| 0.57% | 0.69% | 40.26x | 8.18x | 16.64x | 25.82x | 28.34x | 1.19B | ||
| 0.4% | 0.4% | 14.42x | 4.25x | - | - | - | 1.07B | ||
| -.--% | -.--% | -1.66x | - | 5.03x | 8.22x | 95.07x | 450M | ||
| Average | 0.54% | 0.72% | 5.95x | 6.07x | 9.50x | 22.43x | 33.78x | 7.23B | |
| Weighted average by Cap. | 0.17% | 0.21% | -77.94x | 8.91x | 19.37x | 48.76x | -62.73x |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















